Analyst firms · Wolfe Research · BIIB
Wolfe Research BIIB price target and rating history
Biogen Inc. (BIIB) · Health Care
Wolfe Research rates Biogen Inc. (BIIB) Outperform with a $300 price target, as of its latest action on Aug 13, 2026. It has published 3 rating actions on BIIB since February 2022, including 1 upgrade and 0 downgrades. Across 10 firms with a BIIB price target in the last 12 months, the median target is $231.50. Wolfe Research's $300 is 30% above that.
- Current rating
- Outperform
- Price target
- $300
- Median target, all firms
- $231.50
- Actions on BIIB
- 3
Wolfe Research price target on BIIB
Every Wolfe Research rating on BIIB
- Aug 13, 2026
- Nov 15, 2024
- Feb 4, 2022
How other firms rate BIIB
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Argus Research | Buy | $280 | Oct 29, 2026 |
| Wolfe Research | Outperform | $300 | Aug 13, 2026 |
| Truist Securities | Buy | $235 | Jul 13, 2026 |
| Needham | Buy | $255 | Jun 8, 2026 |
| Evercore ISI | Outperform | May 15, 2026 | |
| UBS | Buy | $225 | Apr 22, 2026 |
| Wells Fargo | Overweight | $250 | Apr 20, 2026 |
| Piper Sandler | Overweight | $214 | Apr 14, 2026 |
| Barclays | Equal Weight | $185 | Feb 20, 2026 |
| H.C. Wainwright | Buy | $228 | Feb 9, 2026 |
| HSBC | Reduce | $143 | Dec 10, 2025 |
Questions about Wolfe Research and BIIB
- What is Wolfe Research's price target for BIIB?
- Wolfe Research's latest stated price target for Biogen Inc. (BIIB) is $300, from its action on Aug 13, 2026.
- What is Wolfe Research's rating on BIIB?
- Wolfe Research rates BIIB Outperform, a bullish rating, as of Aug 13, 2026.
- When did Wolfe Research last change its view on BIIB?
- On Aug 13, 2026, Wolfe Research upgrades to Outperform from Peer Perform, price target $300.
- How does Wolfe Research's BIIB target compare with other analysts?
- Across 10 firms with a BIIB price target in the last 12 months, the median target is $231.50. Wolfe Research's $300 is 30% above that.
More BIIB rating histories
- Argus Research3
- Needham9
- UBS5
- Wells Fargo5
- Piper Sandler4
- Barclays4
- HSBC3
- Stifel5
- Jefferies3
- BMO Capital Markets4
- BofA Securities3
- Morgan Stanley8
- Raymond James3
- Robert W. Baird3
- Mizuho3
- RBC Capital Markets7
- Oppenheimer3
All Wolfe Research ratingsBIIB news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.